Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

TSC1 Antikörper

TSC1 Reaktivität: Human, Maus, Ratte WB, IF Wirt: Kaninchen Polyclonal unconjugated
Produktnummer ABIN121908
  • Target Alle TSC1 Antikörper anzeigen
    TSC1 (Tuberous Sclerosis 1 (TSC1))
    Reaktivität
    • 186
    • 137
    • 51
    • 24
    • 18
    • 2
    • 1
    • 1
    Human, Maus, Ratte
    Wirt
    • 300
    • 16
    • 1
    • 1
    Kaninchen
    Klonalität
    • 302
    • 16
    Polyklonal
    Konjugat
    • 112
    • 37
    • 36
    • 36
    • 32
    • 32
    • 3
    • 3
    • 3
    • 3
    • 3
    • 3
    • 3
    • 3
    • 3
    • 3
    • 3
    Dieser TSC1 Antikörper ist unkonjugiert
    Applikation
    • 229
    • 208
    • 90
    • 28
    • 26
    • 26
    • 16
    • 13
    • 8
    • 6
    • 6
    • 4
    • 3
    • 1
    Western Blotting (WB), Immunofluorescence (IF)
    Spezifität
    This antibody recognises an epitope within the internal region of the 130 kDa tumour suppressor protein, Tumour sclerosis complex 1 (TSC1).
    Aufreinigung
    Affinity chromatography
    Top Product
    Discover our top product TSC1 Primärantikörper
  • Applikationshinweise
    Optimal working dilution should be determined by the investigator.
    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Konzentration
    1.0 mg/mL
    Buffer
    Phosphate buffered saline, 0.02 % Sodium Azide
    Konservierungsmittel
    Sodium azide
    Vorsichtsmaßnahmen
    This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
  • Target
    TSC1 (Tuberous Sclerosis 1 (TSC1))
    Andere Bezeichnung
    TSC1 / Hamartin (TSC1 Produkte)
    Hintergrund
    Mutation within the TSC1 gene is responsible for Tuberous sclerosis (TSC), an autosomal dominant genetic disorder associated with the development of benign tumors (hamartomas), a condition also induced by mutation of the Tumour sclerosis complex 2 (TSC2) gene. Many proteins have been shown to play a role in the regulation of the serine/threonine kinase known as target of rapamycin (TOR), a central component in a complex signaling pathway which controls cell proliferation and cell cycle progression. Negative regulation of TOR activity occurs following the over-expression of the TSC1 and TSC2 gene products, hamartin and tuberin. These act by suppressing the phosphorylation of eukaryotic translation initiation factor 4E binding protein 1 (4EBP1) and ribosomal protein S6 kinase (S6K), downstream targets of TOR involved in mRNA translation. Furthermore the TOR activator protein Rheb has been identified as a target of TSC1-TSC2 complexes.Synonyms: KIAA0243, TSC, Tuberous sclerosis 1 protein
    Gen-ID
    7248
    UniProt
    Q92574
    Pathways
    RTK Signalweg, AMPK Signaling, Regulation of Cell Size, Tube Formation
Sie sind hier:
Kundenservice